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Automated Hovering in Health Care — Watching Over the 5000 Hours
Abstract
The dominant form of health care financing in the United States supports a reactive, visit-based model in
which patients are seen when they become ill, typically during hospitalizations and at outpatient visits. That
care model falls short not just because it is expensive and often fails to proactively improve health, but also
because so much of health is explained by individual behaviors,1 most of which occur outside health care
encounters. Indeed, even patients with chronic illness might spend only a few hours a year with a doctor or
nurse, but they spend 5000 waking hours each year engaged in everything else — including deciding whether
to take prescribed medications or follow other medical advice, deciding what to eat and drink and whether to
smoke, and making other choices about activities that can profoundly affect their health.
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outpatient visits. That care model 
falls short not just because it is 
expensive and often fails to pro-
actively improve health, but also 
because so much of health is ex-
plained by individual behaviors,1 
most of which occur outside 
health care encounters. Indeed, 
even patients with chronic illness 
might spend only a few hours a 
year with a doctor or nurse, but 
they spend 5000 waking hours 
each year engaged in everything 
else — including deciding wheth-
er to take prescribed medications 
or follow other medical advice, de-
ciding what to eat and drink and 
whether to smoke, and making 
other choices about activities that 
can profoundly affect their health.
The increasing attention being 
paid to those 5000 hours takes 
various forms. Employers are fo-
cusing more on employees’ well-
ness — how they eat, whether 
they smoke, and how much they 
exercise. Medication adherence has 
become a more important goal, 
thanks to growing recognition 
that many people with chronic 
conditions fail to take their medi-
cations regularly and therefore do 
not get the benefits that health 
care can provide. Home-based bio-
metric assessments of indicators 
such as glucose level, blood pres-
sure, and weight are emerging as 
part of longitudinal clinical care. 
Transitional care models are be-
ing touted as a way of coordinat-
ing care beyond hospitalization. 
And hospitals and health plans 
are developing “hot-spotter” ap-
proaches, deploying tailored and 
intensive attention to managing 
the care of their most challeng-
ing patients.2 All these activities 
occur outside the conventional, 
billable, clinical encounter — and 
all reflect some sort of hovering 
over people in their daily lives.
Conventional approaches to im-
proving patient engagement along 
these dimensions have been per-
sonnel-intensive — using visiting 
nurses or clinically staffed tele-
medicine services. Although re-
sults have been mixed, in general 
these programs have not fulfilled 
their promise. One problem is 
that using personnel in hovering 
is expensive and therefore diffi-
cult to scale up and to justify, ex-
cept for the very sickest patients, 
some of whom might be too sick 
to benefit. Another problem is 
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that initiating and maintaining 
patient engagement is difficult. 
A large multicenter trial of tele-
monitoring for patients with heart 
failure showed no effect on the 
primary outcomes of rehospital-
ization and death; moreover, 14% 
of those assigned to the interven-
tion group would not use the 
system at all, and nearly half of 
those who did lost interest over 
time. One challenge, therefore, is 
finding a way to automate hover-
ing to reduce its cost. A related 
challenge is figuring out how to 
incorporate it into people’s lives 
in ways that are not just accept-
able and convenient, but ideally 
even welcomed.
Three recent developments sug-
gest that automated hovering may 
offer promise. First are early ef-
forts at payment mechanisms that 
support more accountability for 
health outcomes — including 
nonreimbursement for prevent-
able readmissions and bundling of 
payments around the goals of care 
rather than encounters. These 
changes provide a financial en-
gine to support automated hover-
ing initiatives.
The second development is 
our deepening understanding of 
behavioral economics and the re-
ality that although most people 
want better health and typically 
know what it would take to 
achieve it, the desires, distractions, 
and urgencies of the moment of-
ten get in the way of pursuing 
what’s in their own long-term 
self-interest. Behavioral econom-
ics explains why people are pre-
dictably irrational and provides 
tools for redirecting their behav-
ior with carefully deployed nudg-
es and financial incentives.3 
The third development is the 
expanded reach of both sophisti-
cated and simple technologies — 
cell phones, wireless devices, and 
the Internet — that can help 
health experts connect to people 
during their everyday lives. Nei-
ther wireless devices nor behav-
ioral economics were part of the 
disease-management programs 
that have produced mixed results 
in the past.
There is already considerable 
evidence of the promise of auto-
mated hovering. One study of pa-
tients taking warfarin deployed a 
home-based pill dispenser that 
was electronically tethered to a 
lottery system. Patients were au-
tomatically entered into a daily 
random drawing, with a small 
chance of winning $100 and a 
larger chance of winning $10. 
Each day, patients were electroni-
cally notified if their number had 
come up — which it would do 
about 1 day in 5 — but were eli-
gible for the prize only if they 
had taken their warfarin the pre-
vious day, as signaled by the dis-
penser. The system provided daily 
engagement, the chance of a prize, 
and a sense of anticipated regret: 
no one wants to receive news of 
winning only to be disqualified 
for nonadherence the previous day. 
The expected value of the lottery 
was less than $3 per day, but the 
system reduced the rate of incor-
rect doses from 22% to about 3% 
and reduced the rate of out-of-
range international normalized 
ratios from 35% to 12%.4 Such a 
system could easily be deployed 
to improve medication adherence 
among patients discharged from 
the hospital with congestive heart 
failure or after being treated for 
acute coronary syndromes. This 
system uses technology with an 
engagement strategy informed by 
behavioral economics to hover 
over patients.
In another clinical trial, pa-
tients with difficult-to-control di-
abetes were randomly assigned to 
receive usual care or mentorship 
from another patient who had 
previously managed to tame his 
or her own diabetes. The mentor 
merely had to call the patient once 
a week. The result at 6 months was 
glycated hemoglobin levels more 
than a full percentage point lower 
than those in the control group, 
created by a system requiring 
minimal technology to produce 
hovering that was “automatic” 
from the clinician’s perspective.5
This kind of hovering must be 
targeted to the right clinical and 
social circumstances. The biggest 
savings will probably come from 
reducing preventable hospitaliza-
tions or delaying entrance into 
nursing homes, because that’s 
where so much spending current-
ly occurs. However, cell-phone 
mentors and automatic pill-bot-
tle reminders probably won’t of-
fer much to patients who are fre-
quently hospitalized owing to a 
combination of severe illness and 
challenging life circumstances. 
These patients, at one end of the 
spectrum of intensity of health 
care needs, require a more per-
sonnel-intensive approach that fo-
cuses as much on social circum-
stances as on complex medical 
care. The best targets for auto-
mated hovering are conditions 
whose management depends sub-
stantially on individual patients’ 
behavior. Good targets are medi-
cation adherence in patients with 
heart failure or acute coronary 
syndromes and efforts to manage 
diet, exercise, or weight. The 
amount of hovering required to 
engage patients in healthy behav-
iors during those 5000 hours will 
depend critically on the intensity 
of their needs, but automated 
systems might be a cost-effective 
solution for many patients.
There are potential concerns. 
Some people might worry that 
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too much hovering will erode pa-
tients’ sense of personal respon-
sibility or that hovering in one 
area might distract providers or 
patients from other important 
health issues. Others may worry 
that hovering is too intrusive or 
paternalistic — though patients 
could easily opt out, and it’s ar-
guably no more paternalistic than 
traditional approaches to improv-
ing patient outcomes. It will be 
important to ensure that new 
hovering efforts are evaluated 
carefully, with assessment of both 
intended and potential unintend-
ed consequences.
And of course, there is a con-
siderable amount we don’t know 
about these approaches: the kinds 
of patients, conditions, or set-
tings for which they will be the 
most useful; the organizations 
(hospitals, employers, or insur-
ers) that should be the ones to 
deploy them; and how to make 
them heard over the din of every-
thing else that competes for atten-
tion while remaining unintrusive 
enough that nudges don’t become 
self-defeating nags. There are both 
clinical and research opportunities 
in pursuing an approach that is 
just as rigorous as our approach 
to other areas of medicine. Care-
ful iterative testing is essential 
because these new forms of pa-
tient engagement, whatever shape 
they take, will be central to im-
proving population health in our 
future health care system.
Disclosure forms provided by the authors 
are available with the full text of this article 
at NEJM.org.
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Automated Hovering in Health Care
Three decades of research fo-cused predominantly on 
costs and the use of services 
among Medicare beneficiaries 
has repeatedly found wide re-
gional variations in health care 
experiences and health system 
performance.1 Much less atten-
tion has been paid to variations 
in access to care and their asso-
ciated implications for quality of 
care and health outcomes. Our re-
cent Commonwealth Fund report, 
“Rising to the Challenge: Results 
from a Scorecard on Local Health 
System Performance,”2 shows that 
when we look beyond state aver-
ages, there are staggeringly wide 
gaps in people’s ability to gain ac-
cess to care in different commu-
nities around the country. We 
also find a strong and persistent 
association between access and 
health care quality, including the 
receipt of preventive care.
Simply put, where a person 
lives matters — it influences the 
ability to obtain health care, as 
well as the probable quality of 
care that will be received — 
though it should not matter in an 
equitable health care system. This 
and other Scorecard findings have 
important implications that are 
relevant to national policy reforms 
and to newly available resources 
for improving access and quality 
of care.
The Scorecard tracks 43 health 
system performance measures 
grouped into four dimensions: 
access, prevention and treatment, 
potentially avoidable hospital use 
and cost, and healthy lives. The 
analysis examined the range of 
variation across all 306 hospital 
referral regions (HRRs) — region-
al health care markets defined 
with the use of patient-flow data 
for the Dartmouth Atlas of Health 
Care — and drew largely from 
publicly available data, generally 
from 2008 to 2010. (See the Sup-
plementary Appendix, available 
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